Novavax, Inc. Aktie News

Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant earlier this year, the company said.

H5N1 bird flu was detected this week in Michigan and Australia. It's the first detection in humans since March, when news of an outbreak in cattle emerged.

While it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years. While there could be several reasons for this, such as the COVID-19 pandemic bringing the value of biotechnology to the forefront or even the expansion of education in the biosciences, the fact remains – biotech is getting more attention than ever...

Novavax just signed a lucrative agreement with a biotech giant. Inovio Pharmaceuticals is inching closer to launching its leading candidate.

Novavax stock surged after the company announced a partnership with pharma giant Sanofi. The biotech stock has spent the past few years in the doldrums after sales of its coronavirus vaccine disappointed investors.

GameStop (NYSE: GME ) and AMC (NYSE: AMC ) meme stocks rose substantially last week, gaining over 70%. The return of ‘Roaring Kitty', prominent investor Keith Gill, has traders wondering which meme stocks to buy next.

Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's board, after the COVID-19 vaccine maker struck a licensing deal with Sanofi.

Novavax recently entered into a lucrative, multitiered deal with Sanofi. The agreement helps improve Novavax's prospects.